Vasily Karagodin

Prof. Dr. Vasily Karagodin

Higher Engineering School "New Materials and Technologies", Plekhanov Russian University of Economics, Moscow, Moskva, Russia
orcid

Research Focus & Metrics

Academic Career Length

53Years (1974-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in Phytomedicine
Verified
Journal Article
Closed access
ISIgor Sobenin
Igor Sobenin
IAIrina V. Andrianova
Irina V. Andrianova
KLKonstantin Y. Lakunin
Konstantin Y. Lakunin
Vasily KaragodinVasily Karagodin
Vasily Karagodin
YBYuri Bobryshev
Yuri Bobryshev
AOAlexander N. Orekhov
Alexander N. Orekhov

Verified
Journal Article
Open access
PDF file
Margarita A. SazonovaMargarita A. Sazonova
Margarita A. Sazonova
VSVasily V. Sinyov
Vasily V. Sinyov
ARAnastasiya Ryzhkova
Anastasiya Ryzhkova
MSMarina D. Sazonova
Marina D. Sazonova
TKTatiana Kirichenko
Tatiana Kirichenko
ISIgor Sobenin
Igor Sobenin
Chronic stress is a combination of nonspecific adaptive reactions of the body to the influence of various adverse stress factors which disrupt its homeostasis, and it is also a corresponding state of the organism’s nervous system (or the body in general). We hypothesized that chronic stress may be one of the causes occurence of several molecular and cellular types of stress. We analyzed literary sources and considered most of these types of stress in our review article. We examined genes and mutations of nuclear and mitochondrial genomes and also molecular variants which lead to various types of stress. The end result of chronic stress can be metabolic disturbance in humans and animals, leading to accumulation of reactive oxygen species (ROS), oxidative stress, energy deficiency in cells (due to a decrease in ATP synthesis) and mitochondrial dysfunction. These changes can last for the lifetime and lead to severe pathologies, including neurodegenerative diseases and atherosclerosis. The analysis of literature allowed us to conclude that under the influence of chronic stress, metabolism in the human body can be disrupted, mutations of the mitochondrial and nuclear genome and dysfunction of cells and their compartments can occur. As a result of these processes, oxidative, genotoxic, and cellular stress can occur. Therefore, chronic stress can be one of the causes forthe occurrence and development of neurodegenerative diseases and atherosclerosis. In particular, chronic stress can play a large role in the occurrence and development of oxidative, genotoxic, and cellular types of stress.

21 December 2015 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
Vasily KaragodinVasily Karagodin
Vasily Karagodin
ISIgor Sobenin
Igor Sobenin
AOAlexander N. Orekhov
Alexander N. Orekhov
Garlic is believed to produce beneficial changes in different cardiovascular risk factors, thus possessing antiatherosclerotic properties. The hypotensive and cholesterol-lowering effects were investigated in two studies in men with mild arterial hypertension and in men with mild hypercholesterolemia. Eight-week treatment resulted in the reduction of both systolic and diastolic blood pressure by 5.2% (P=0.008) and 4.0% (P=0.014), respectively. In hypolipidemic study, the 12-week treatment resulted in a decrease in LDL cholesterol by 11.8% (P=0.002), while HDL cholesterol increased by 11.5% (P=0.013). In men with cerebral atherosclerosis it has been demonstrated that 14-days treatment inhibited ADP-induced platelet aggregation by 25.4% (P<0.05) and increased plasma fibrinolytic activity by 22.4% (P<0.05). One more study was performed in high-risk patients to evaluate the changes of prognostic cardiovascular risk that was calculated using algorithms derived from Framingham and Muenster Studies. Twelve-months treatment lowered 10-years prognostic risk of CHD by 13.2% in men (P=0.005), and by 7.1% in women (P=0.040). Ten-year prognostic risk of acute myocardial infarction and sudden coronary death was lowered by 26.1% in men (P=0.025). The Atherosclerosis Monitoring and Atherogenicity Reduction Study (AMAR) was designed to estimate the effect of two-year treatment with garlic powder pills on the progression of carotid atherosclerosis in asymptomatic men. A significant correlation has been revealed between the changes in blood serum atherogenicity and the changes in carotid intima-media thickness (r=0.144, P=0.045). Evidence obtained from these studies as well as series of double-blinded placebo-controlled clinical trials indicates that garlic powder pills are effective for prevention of cardiovascular disorders.

18 September 2019 in Biomolecules
Verified
Journal Article
Open access
PDF file
Margarita A. SazonovaMargarita A. Sazonova
Margarita A. Sazonova
VSVasily V. Sinyov
Vasily V. Sinyov
ARAnastasiya Ryzhkova
Anastasiya Ryzhkova
MSMarina D. Sazonova
Marina D. Sazonova
ZKZukhra Khasanova
Zukhra Khasanova
ISIgor Sobenin
Igor Sobenin
In the present work, a pilot creation of four cybrid cultures with high heteroplasmy level was performed using mitochondrial genome mutations m.12315G>A and m.1555G>A. According to data of our preliminary studies, the threshold heteroplasmy level of mutation m.12315G>A is associated with atherosclerosis. At the same time, for a mutation m.1555G>A, such a heteroplasmy level is associated with the absence of atherosclerosis. Cybrid cultures were created by fusion of rho0-cells and mitochondria from platelets with a high heteroplasmy level of the investigated mutations. To create rho0-cells, THP-1 culture of monocytic origin was taken. According to the results of the study, two cybrid cell lines containing mutation m.12315G>A with the heteroplasmy level above the threshold value (25% and 44%, respectively) were obtained. In addition, two cybrid cell lines containing mutation m.1555G>A with a high heteroplasmy level (24%) were obtained. Cybrid cultures with mtDNA mutation m.12315G>A can be used to model both the occurrence and development of atherosclerosis in cells and the titration of drug therapy for patients with atherosclerosis. With the help of cybrid cultures containing single nucleotide replacement of mitochondrial genome m.1555G>A, it is possible to develop approaches to the gene therapy of atherosclerosis.

17 October 2012 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
ISIgor Sobenin
Igor Sobenin
Vasily KaragodinVasily Karagodin
Vasily Karagodin
AMAlexandra А. Melnichenko
Alexandra А. Melnichenko
YBYuri Bobryshev
Yuri Bobryshev
Alexander N. OrekhovAlexander N. Orekhov
Alexander N. Orekhov

1 May 2016 in Biomeditsinskaya Khimiya
Verified
Journal Article
Closed access
Vasily N SukhorukovVasily N Sukhorukov
Vasily N Sukhorukov
Vasily KaragodinVasily Karagodin
Vasily Karagodin
AOA.N. Orekhov
A.N. Orekhov
One of the first manifestations of atherosclerosis is accumulation of extra- and intracellular cholesterol esters in the arterial intima. Formation of foam cells is considered as a trigger in the pathogenesis of atherosclerosis. Low density lipoprotein (LDL) circulating in human blood is the source of lipids accumulated in the arterial walls. This review considered features and role in atherogenesis different modified forms of LDL: oxidized, small dense, electronegative and especially desialylated LDL. Desialylated LDL of human blood plasma is capable to induce lipid accumulation in cultured cells and it is atherogenic. LDL possesses numerous alterations of protein, carbohydrate and lipid moieties and therefore can be termed multiple-modified LDL. Multiple modification of LDL occurs in human blood plasma and represents a cascade of successive changes in the lipoprotein particle: desialylation, loss of lipids, reduction in the particle size, increase of surface electronegative charge, etc. In addition to intracellular lipid accumulation, stimulatory effects of naturally occurring multiple-modified LDL on other processes involved in the development of atherosclerotic lesions, namely cell proliferation and fibrosis, were shown.